News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Approves First Generic Versions of Roche (RHHBY)'s Boniva


3/20/2012 7:48:35 AM

The first generic versions of Roche's bone-strengthening drug Boniva have been approved by the U.S. Food and Drug Administration. Boniva, known generically as ibandronate, is taken once a month to treat or prevent osteoporosis in women after menopause. Mylan Pharmaceuticals Inc and privately held Apotex Inc and Orchid Healthcare are the manufacturers that have gained approval to make generic 150-milligram ibandronate tablets, the FDA said.

Read at Fox News
Read at CBS News


comments powered by Disqus
Fox News
CBS News
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES